Health Tech Capitol | Madison company’s study paving the way for an autism blood test is published in scientific journal
16416
post-template-default,single,single-post,postid-16416,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Madison company’s study paving the way for an autism blood test is published in scientific journal

06 Sep Madison company’s study paving the way for an autism blood test is published in scientific journal

Posted at 09:17h in Uncategorized by
0 Likes

A Madison company that says its findings will “revolutionize” the way autism spectrum disorder is diagnosed and treated is getting a boost from a scientific publication.

Research conducted by Madison-based NeuroPointDX in collaboration with the MIND Institute at the University of California-Davis shows subtle differences in blood can identify some children as young as 18 months with autism spectrum disorder.

The findings are being published Thursday in a peer-reviewed scientific journal, Biological Psychiatry, for the first time, and a blood test for autism is expected to be available before the end of the year, NeuroPointDX CEO Elizabeth Donley said.

Read more at the Wisconsin State Journal

No Comments

Sorry, the comment form is closed at this time.